NEW CP110 Evaluating Myeloid Stem Cell Disorders by Flow Cytometry (AML and Myelodysplasia)
8:00–11:30 am
3.0 CME/CE CREDITS
This session focuses on the utility of flow cytometry in the diagnosis of myeloid stem cell disorders, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The course will cover the immunophenotypic patterns of normal myeloid blasts and precursors during maturation and how such patterns are disordered in AML and MDS. The first segment of the course will review principles of evaluating blast populations in AML, including such topics as genetic correlates with flow cytometry and residual disease testing. The second segment will emphasize approaches to evaluating MDS using flow cytometry, including how to recognize aberrant immunophenotypic patterns in myeloid blast and maturing myeloid populations.
You will learn to:
- Recognize immunophenotypic patterns associated with normal maturation on myeloid blasts and maturing myeloid forms
- Use flow cytometry to differentiate normal myeloid maturation from the abnormal maturation typical of acute myeloid leukemia or of a myeloid stem cell disorder such as myelodysplasia
- Understand the role of flow cytometry in evaluating acute myeloid leukemia and myelodysplastic syndromes
Faculty
Sindhu Cherian, MD
Sa Wang, MD